Presentation is loading. Please wait.

Presentation is loading. Please wait.

Moving from SDTM IG 3.1.2 to 3.1.4 Overview Monika Kawohl Principal Statistical Programmer Accovion.

Similar presentations


Presentation on theme: "Moving from SDTM IG 3.1.2 to 3.1.4 Overview Monika Kawohl Principal Statistical Programmer Accovion."— Presentation transcript:

1 Moving from SDTM IG to Overview Monika Kawohl Principal Statistical Programmer Accovion

2 German Speaking CDISC UG Meeting, 25-Sep Are we all up-to-date with the latest developments? Monthly CDISC Teams Update Webinars (free) (slides/recordings available for members) RS? DU? RFICDTC? AESOCCD? SR? MO? EC? AP? BPI? Disease Response Domain (SDTMIG 3.1.3) Date/Time of Informed Consent in DM (SDTMIG 3.1.3) Primary System Organ Class Code in AE (SDTMIG 3.1.3) Device in Use Domain (Devices Supplement to SDTMIG in Parkinsons Draft UG) Skin Response Domain (Draft SDTMIG Batch 1 (or TB UG)) Morphology Domain (Draft SDTMIG Batch 2 (or multiple Therapeutic Area UGs)) Exposure as Collected Domain (Draft SDTMIG Batch 1) Prefix for Associated Persons Domains (Supplement to SDTMIG in Parkinsons Draft UG) QSCAT value for Brief Pain Inventory Questionnaire (Controlled Terminology File for QS) def:WhereClauseDef? new element in Draft define.xml v2.0

3 German Speaking CDISC UG Meeting, 25-Sep SDTM IG (Final) DM Update (previously amendment) AE Update (previously amendment) TS Update Oncology Domains Tumor Identification (TU), Tumor Results (TR) Disease Response (RS) – applicable also for other diseases Variable Length Considerations Minor Edits (Labels, Roles, etc.) Working with SDTM IG (3.1.2 IG Annotations) Its all about finding the correct

4 German Speaking CDISC UG Meeting, 25-Sep SDTM IG Batch 1 (Draft) Exposure Domains Supplement Exposure (EX), Exposure as Collected (EC) – Interventions Domains Immunogenicity Domains Supplement Immunogenicity Specimen Assessments (IS) - Findings Domain assessments, which determine whether a therapy caused/induced an immune response (e.g. vaccines) Skin Response (SR) - Findings About Domain dermal responses to antigens Reproductive Details Domain Reproductive Details (RD) – Findings Domains e.g. childbearing status, reproductive history (# pregnancies, # births)

5 German Speaking CDISC UG Meeting, 25-Sep SDTM IG Batch 2 (in preparation) Cardiovascular Physiology (CV) - Findings Domain Results of a cardiovascular diagnostic procedure Death Details (DD) – Findings Domain Death details collected in addition to AE data Microscopic (MI) - Findings Domain Results from a microscopic study of characteristic tissue abnormalities Morphology (MO) - Findings Domain Macroscopic results seen by the naked eye or results from procedures Procedures (PR) - Interventions Domain Details on therapeutic or diagnostic procedures (NOT their results) Subject Status Domain (SS) – Findings Domains, e.g. survival status

6 German Speaking CDISC UG Meeting, 25-Sep SDTM IG Batch 2 (in preparation) SDS Team Proposal Documents Alternative Method of submitting Supplemental Qualifier variables allow non-standard variables to be included in the parent datasets Conditions when this practice would be permitted Managing Multiple Dates e.g., date of symptom onset, date diagnosed, date confirmed 2 options: - Findings About (utilize existing concept) - Clinical Timings (new concept)

7 German Speaking CDISC UG Meeting, 25-Sep Therapeutic/Disease Area Standards Alzheimers Disease (Final) Tuberculosis (Final) Pain (Final) Parkinsons Disease (Draft) Virology (Draft) – VR, PF, PG, PB, SB Polycystic Kidney Disease (in preparation) Cardiovascular Disease (in preparation)

8 German Speaking CDISC UG Meeting, 25-Sep Therapeutic/Disease Area (TA/DA) Standards SDTM Implementation for a specific TA/DA some include annotated CRFs Built based on SDTMIG Conventions for use of existing domains e.g., Primary Diagnosis => MH Introduction of new domains for provisional use Associated Persons (AP--) domains (see Parkinsons) Device domains (Draft) (see Parkinsons) Contents of TA/DA standards also usable for other indications

9 German Speaking CDISC UG Meeting, 25-Sep Other Pharmacogenomics/Genetics Domains (updated Draft in preparation) Questionnaires aCRFs and specifications incl. in Pain TA User Guide Valid value ranges (char. + num.) in SUPPQS Terminology for 30+ questionnaires (Final) – separate CT File


Download ppt "Moving from SDTM IG 3.1.2 to 3.1.4 Overview Monika Kawohl Principal Statistical Programmer Accovion."

Similar presentations


Ads by Google